Evidence map›Paper›PMID 22841154›Full record

ArticleEmerging infectious diseases2012

Population diversity among Bordetella pertussis isolates, United States, 1935-2009.

Amber J Schmidtke, Kathryn O Boney, Stacey W Martin, Tami H Skoff, M Lucia Tondella, Kathleen M Tatti

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Review
  2. Genomic epidemiology and evolution ofEmerging microbes & infections · 2025
    Article
  3. Review
  4. Article
  5. mSystems · 2025
    Article
  6. Frontiers in cellular and infection microbiology · 2025
    Article
  7. Review
  8. Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024
    Review
  9. Screening of Novel Drug Targets and Drug Design forCurrent research in microbial sciences · 2024
    Article
  10. Article
  11. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amber J SchmidtkeCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Kathryn O Boney
Stacey W Martin
Tami H Skoff
M Lucia Tondella
Kathleen M Tatti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the 1980s, pertussis notifications in the United States have been increasing. To determine the types of Bordetella pertussis responsible for these increases, we divided 661 B. pertussis isolates collected in the United States during 1935-2009 into 8 periods related to the introduction of novel vaccines or changes in vaccination schedule. B. pertussis diversity was highest from 1970-1990 (94%) but declined to ≈ 70% after 1991 and has remained constant. During 2006-2009, 81.6% of the strains encoded multilocus sequence type prn2-ptxP3-ptxS1A-fim3B, and 64% were multilocus variable number tandem repeat analysis type 27. US trends were consistent with those seen internationally; emergence and predominance of the fim3B allele was the only molecular characteristic associated with the increase in pertussis notifications. Changes in the vaccine composition and schedule were not the direct selection pressures that resulted in the allele changes present in the current B. pertussis population.

Indexed as

Genetic VariationAllelesAntigens, BacterialBordetella pertussisDisease NotificationFimbriae ProteinsHumansMinisatellite RepeatsMultilocus Sequence TypingPertussis ToxinPertussis VaccineUnited StatesVaccinationVirulence Factors, BordetellaWhooping CoughAntigens, Bacterialfim3 protein, BordetellaFimbriae ProteinsPertussis ToxinPertussis VaccineVirulence Factors, Bordetella

Identifiers

PMID22841154
PMCPMC3414039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.